GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

A Task Force has been convened by local MP, Michelle Scrogham, to look at the support provided to staff, local suppliers, and the local ...

Tucker Kraft is making a big impression on the NFL. But even at the pinnacle of success, he’s never forgotten where he came ...

GSK featured in my "Top 10" pharma social media ... He likens the company's history with social media to learning to ride a bicycle, and says while it is important to understand the opportunities ...

TD Cowen analyst Steve Scala maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of $45.00. The ...

GSK GSK stock has declined 20.2% in the past three months compared with a decrease of 12.3% for the industry. The stock has also underperformed the sector and the S&P 500 index, as seen in the ...

GSK's former head of vaccines R&D – Dr Emmanuel ... The London-based company was founded by venture capital firm Medicxi in 2019, but has now come out of stealth mode with financial backing ...

Survival Rate and 37% Reduction in Risk of Death Multiple Patients with Complete Responses (CRs) and/or Partial Response (PR) ...